Invest in intelligence that delivers

Contact
Search
Close this search box.

Perspective
is everything.

Across the pharma lifecycle, an accurate and complete market view is essential to stay ahead of the curve and uncover emerging healthcare trends.
Visit our portal

Think beyond the brand.

The more you understand the landscape, the better you can align with market needs and gain a competitive edge.

Identify:

  • Unmet market, prescriber, and patient needs 
  • Disconnect between what prescribers say versus what they do 
  • Gaps, threats, and disruptors 

Broaden your
perspective,
with Spherix.

We combine robust, independent market data with deep therapeutic expertise and impeccable focus on delivering commercial value.

Harness the power of holistic market intelligence. Make better decisions and unlock opportunities.

We view the market landscape through the lens of your business and deliver customized strategic advisory services.

Spherix delivers:

Market Insights

Gain an unbiased perspective of the market and its potential, independently assess launches, understand the patient journey and prescribers' perspectives, and gauge the impact of disruptive events.

Strategic Sessions

Interactive on-site or virtual  sessions with Spherix therapeutic experts, highlighting commercially relevant analyses, contextual data, and custom insights tailored to your business.

Advisory Services

Fortify your strategy and tactics with our industry experts who are well-equipped to deliver strategic advisory services across the product lifecycle.

Spherix is dedicated to the therapeutic areas we cover.

Learn more about the specialty markets we cover
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
Gastroenterology Indications Covered:
  • Crohn’s Disease Ulcerative Colitis
  • IBS-C
  • Eosinophilic Esophagitis
  • MASLD/MASH (NAFLD/NASH)
  • Clostridioides Difficile
Visit the Spherix portal for the full spectrum of our Gastroenterology offering Download the Gastroenterology publication plan
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

Our therapeutic experts are always just a click or call away...

  • Plugged into the ever-evolving landscape
  • Ready to provide an unbiased view of the  landscape
  • Insightfully answer real-time questions
  • Highlight opportunities Identify disruptors
Contact Us

Capitalize on commercially relevant insights and advisory services across the pharma lifecycle.

Independent, holistic intelligence informs tailored support that matches the needs of your business.
Gain an unbiased perspective of the market and its potential.
Reveal the ‘why’ behind treatment decisions and understand the patient journey.
Add context to trending topics and gauge the impact of disruptive events.
Independently assess launches and benchmark history of analogs.
Understand the prescriber’s perspective of the competitive landscape.

Shape what’s next with market intelligence that is trusted and influential.

We work with 17 of the top 20 pharma/biotech organizations, and our expertise is a go-to resource for leading brands, industry media outlets, financial analysts, professional organizations, and patient advocacy groups.
Learn more about the Spherix offering

Pharma

Key Opinion Leaders

Professional Organizations

Media Outlets

Patient Advocacy Groups

Financial Analyst Firms

Spherix offerings have provided us with an external source of reference which, when compared with our custom market research, led us to include a potentially lucrative segment of physicians in our target list leading to increased growth.”
Pharmaceutical In-Line Brand Commercial Strategy Lead
Spherix offerings have provided us with an external source of reference which, when compared with our custom market research, led us to include a potentially lucrative segment of physicians in our target list leading to increased growth.”
Pharmaceutical In-Line Brand Commercial Strategy Lead
Spherix offerings have provided us with an external source of reference which, when compared with our custom market research, led us to include a potentially lucrative segment of physicians in our target list leading to increased growth.”
Pharmaceutical In-Line Brand Commercial Strategy Lead
Spherix offerings have provided us with an external source of reference which, when compared with our custom market research, led us to include a potentially lucrative segment of physicians in our target list leading to increased growth.”
Pharmaceutical In-Line Brand Commercial Strategy Lead
Spherix offerings have provided us with an external source of reference which, when compared with our custom market research, led us to include a potentially lucrative segment of physicians in our target list leading to increased growth.”
Pharmaceutical In-Line Brand Commercial Strategy Lead
Previous
Next

Media

View all media

04.08.2024

Pfizer’s Velsipity poised to outpace BMS’ Zeposia in ulcerative colitis market, but must head off further competition: analysts

04.08.2024

As Humira biosim sales languish, Boehringer Ingelheim plots layoffs in pivot to hybrid marketing model

04.05.2024

US Gastroenterologists Project Swift Uptake of Madrigal Pharmaceuticals’ Rezdiffra (resmetirom) for the Treatment of…

03.22.2024

Gastroenterologists Slow to Adopt Eli Lilly’s Omvoh, Pfizer’s Velsipity, and Takeda’s subcutaneous formulation of Entyvio for…

Talk to an expert

Gianna Melendez
Franchise Head, Dermatology

Contact

Jim Hickey
Franchise Head, Gastroenterology

Contact

Maxine Yarnall
Franchise Head, Rheumatology

Contact

Meghan Weiss
Franchise Head, Nephrology

Contact

Blaine Cloud, PhD
Franchise Head, Neurology

Contact

Blaine Cloud, PhD
Franchise Head, Ophthalmology

Contact

Partner with an intelligence team hyper-focused on your specialty.

DERMATOLOGY
Gastroenterology
Rheumatology
Nephrology
NEUROLOGY
OPHTHALMOLOGY

Independent, holistic intelligence informs tailored support that matches the needs of your business.

Our continuous market intelligence provides an unbiased view of the landscape within rapidly evolving specialty markets, including quarterly market trending and a fresh infusion of event-driven and variable content with each wave of research.
Sign up for alerts, market insights and exclusive content in your inbox.
Subscribe
Linkedin

Download our publication plan

or

Visit our portal for the searchable format

©2024 Spherix. All Rights Reserved.

Site Map

Dermatology

Expertise

5

dedicated team members

8

years of
continuous tracking

36

studies published annually

Indications

  • Alopecia Areata
  • Atopic Dermatitis
  • Hidradenitis Suppurativa
  • Plaque Psoriasis
  • Prurigo Nodularis
  • Vitiligo Team Lead
See all Dermatology publications in our portal

Team Lead

Linkedin Envelope

Gianna Melendez
Franchise Head, Dermatology

Gianna has been with Spherix since 2017. Prior to Spherix, Gianna received her master’s degree in experimental psychology from Saint Joseph’s University. She previously worked at the University of Pennsylvania conducting clinical trials focusing on women’s health.
Sign up for alerts, market insights and exclusive content in your inbox.

Spherix is excited to announce our expansion into an additional, rapidly evolving specialty market:

HEMATOLOGY

Throughout 2024, we will be publishing over
10 groundbreaking studies covering a wide range of indications within classical hematology.